David Roth - Chief Medical Officer at Syros Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
SYRS on Nasdaq
All Insider Reports
All Insider Reports

David Roth - trading volume in the past year for Syros Pharmaceuticals, Inc.

Holdings reported by David Roth for Syros Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 26.7K $137K $5.12 Mar 31, 2024 Direct Common Stock
Common Stock 0 $0 $4.95 Apr 3, 2024 Direct

Transactions reported by David Roth for Syros Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.